SIPAL

Business news, market intelligence, and global industry analysis.

The Latest

Can fewer infusions improve adherence in Fabry disease enzyme replacement therapy?

CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m

What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)

CVGI surges 54% as CVG names Zoox strategic supplier and issues $700M revenue outlook for 2026

Representative image of an Accenture office building. The company is expanding its footprint in AI-driven insurance platforms and European defense engineering, as highlighted in its recent investments in Reserv and SIPAL.

Accenture (NYSE: ACN) doubles down on AI insurance and defense with Reserv investment, SIPAL buyout

Accenture (NYSE: ACN) fuels insurance AI with Reserv investment and strengthens defense engineering via SIPAL buyout, aligning with global reinvention strategy.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

June 5, 2025